FRT
39
3
ETR
65
4
ZBH
71
3
RIG
35
6
SPG
50
4
CHRW
54
3
CMG
64
3
CSX
43
3
MAT
43
2
PG
43
2
AVB
55
3
DTE
54
5
EIX
62
3
AEE
56
5
DHI
29
2
DD
45
4
SLB
45
4
PDCO
77
2
O
30
10
ES
29
3
FRT
39
3
ETR
65
4
ZBH
71
3
RIG
35
6
SPG
50
4
CHRW
54
3
CMG
64
3
CSX
43
3
MAT
43
2
PG
43
2
AVB
55
3
DTE
54
5
EIX
62
3
AEE
56
5
DHI
29
2
DD
45
4
SLB
45
4
PDCO
77
2
O
30
10
ES
29
3
Financhill
Back

Clearside Biomedical 10K Form

Sell
27

CLSD
Clearside Biomedical

Last Price:
$0.91
Seasonality Move:
14.23%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive CLSD News And Ratings

See the #1 stock for the next 7 days that we like better than CLSD

CLSD Financial Statistics

Sales & Book Value

Annual Sales: $8.2M
Cash Flow: $-6M
Price / Cash Flow: 0
Annual Sales: $-0.47
Price / Book: 0

Profitability

EPS (TTM): -0.45000
Net Income (TTM): $-31.9M
Gross Margin: $7.9M
Return on Equity: 0%
Return on Assets: -92.84%

Clearside Biomedical Earnings Forecast

Key Clearside Biomedical Financial Ratios

  • The Gross Profit Margin over the past 5 years for CLSD is 95.68%.
  • The Selling, General & Administrative Expenses for CLSD have been equal to 144.29% of Gross Profit Margin.
  • The Research & Development expenses have been 253.42% of Revenue.
  • The Interest Expense is -28.81% of Operating Income.
  • The Net Earning history of CLSD is -394.91% of Total Revenues.
  • Per Share Earnings over the last 11 years have been positive in 4 years.

Clearside Biomedical Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: CLSD
CUSIP: 185063
Website: clearsidebio.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 4.49
Quick Ratio: 4.36

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

CLSD Technical Analysis vs Fundamental Analysis

Sell
27
Clearside Biomedical (CLSD) is a Sell

Is Clearside Biomedical a Buy or a Sell?